News

Ordinary General Meeting of CyBio AG Approves the Squeeze-out Merger with Analytik Jena AG

Jena, Germany, May 22, 2014 – This year’s Ordinary General Meeting of CyBio AG, which was held in Jena today, has approved the transfer of the minority interest shares of the Company to Analytik Jena AG as part of the merger of CyBio AG into Analytik Jena AG with a majority vote. In total, 99,8 % of the share capital in attendance voted for this move. As part of the squeeze-out merger, Analytik Jena AG will acquire all the remaining shares of CyBio AG in return for payment of compensation in cash and will merge the activities of the subsidiary with its own core activities in the Life Science area. Analytik Jena AG decided yesterday evening to increase the cash payment from EUR 1.70 per CyBio share to EUR 1.75 per CyBio share. This decision was made because the base interest rate used to calculate the cash payment has fallen from 2.75% to 2.50% between April 3, 2014, when the level of the cash payment was set, and the settlement date today.

At today’s General Meeting, 6,636,526 shares with the same number of votes were represented, out of CyBio’s share capital of EUR 7,200,000 at the time of the vote. This corresponds to 92.17 % of the Company’s share capital. In addition to the approval of the transfer of the minority interest shares of CyBio AG to Analytik Jena AG (agenda item 5), agenda items two to four were also put to a vote. These were the resolutions submitted by the Executive Board and Supervisory Board regarding the discharge of the members of the Executive Board and Supervisory Board, as well as the election of an auditor. All items on the agenda were approved with a majority of the vote.